These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36481295)

  • 21. Compliance revisited: pharmaceutical drug trials in the era of the contract research organization.
    Jonvallen P
    Nurs Inq; 2009 Dec; 16(4):347-54. PubMed ID: 19906285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor variants and the development of centrally acting medications
.
    Neale SA; Kambara K; Salt TE; Bertrand D
    Dialogues Clin Neurosci; 2019; 21(2):149-157. PubMed ID: 31636489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Driving external chemistry optimization via operations management principles.
    Bi FC; Frost HN; Ling X; Perry DA; Sakata SK; Bailey S; Fobian YM; Sloan L; Wood A
    Drug Discov Today; 2014 Mar; 19(3):289-94. PubMed ID: 23973340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer.
    Gobbini E; Pilotto S; Pasello G; Polo V; Di Maio M; Arizio F; Galetta D; Petrillo P; Chiari R; Matocci R; Di Costanzo A; Di Stefano TS; Aglietta M; Cagnazzo C; Sperduti I; Bria E; Novello S
    Clin Lung Cancer; 2018 Mar; 19(2):191-198. PubMed ID: 29153968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mobile contract services: what you need to know.
    Inman M
    Radiol Manage; 2000; 22(5):38-42. PubMed ID: 11151320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Navigating the clinical trial pathway: Conception, design, execution, and results dissemination.
    Sampalis JS; Watson J; Boukas S; Boukas M; Harvey N; Machado S; Bordeleau M; Rampakakis E
    Surgery; 2017 Mar; 161(3):576-583. PubMed ID: 28190508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pirates of Clinical Trials.
    Pergolizzi J; Pergolizzi C; LeQuang JAK
    Cureus; 2023 Oct; 15(10):e47819. PubMed ID: 38022306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative analysis of quality management standards for contract research organisations in clinical trials.
    Murray E; McAdam R
    Int J Health Care Qual Assur; 2007; 20(1):16-33. PubMed ID: 18240505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging trends in contract research industry in India.
    Drabu S; Gupta A; Bhadauria A
    Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Collaboration with clinical research organizations : Introduction of a questionnaire for clinical study centers].
    Adorf A; Lorenz K; Feltgen N; Wilhelm B;
    Ophthalmologie; 2022 Jun; 119(6):577-581. PubMed ID: 34923599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Participation in clinical drug studies: motivations and barriers.
    Cunny KA; Miller HW
    Clin Ther; 1994; 16(2):273-82; discussion 271-2. PubMed ID: 8062322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redefining feasibility in clinical trials: Collaborative approaches for improved site selection.
    Bruneau B; Surdam K; Bland A; Krueger A; Wise A; Cotarlan A; Leviton A; Jouravleva E; Fitzgerald G; Frost HN; Cutler HF; Buddle J; Diaz LG; Cohen M; Sacco NA; Washington R; Mauermann S; Chen V; Bastek A
    Contemp Clin Trials Commun; 2024 Aug; 40():101291. PubMed ID: 39105082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.
    Waterhouse DM; Harvey RD; Hurley P; Levit LA; Kim ES; Klepin HD; Mileham KF; Nowakowski G; Schenkel C; Davis C; Bruinooge SS; Schilsky RL
    JCO Oncol Pract; 2020 Jul; 16(7):417-421. PubMed ID: 32396491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Private management of a public service: what can be learned from the CROS experience?
    McGowan T
    Hosp Q; 2003; 6(4):33-8, 2. PubMed ID: 14628525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing the use of CROs by academia and small companies.
    Lane RF; Friedman LG; Keith C; Braithwaite SP; Frearson JA; Lowe DA; Longo FM; Refolo LM; Watterson DM; Tsaioun K; Shineman DW; Fillit HM
    Nat Rev Drug Discov; 2013 Jul; 12(7):487-8. PubMed ID: 23812255
    [No Abstract]   [Full Text] [Related]  

  • 36. Incorporating Site-less Clinical Trials Into Drug Development: A Framework for Action.
    Hirsch IB; Martinez J; Dorsey ER; Finken G; Fleming A; Gropp C; Home P; Kaufer DI; Papapetropoulos S
    Clin Ther; 2017 May; 39(5):1064-1076. PubMed ID: 28413148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategic partnership: the successful contract laboratory-sponsor relationship.
    Scozzie JA
    Qual Assur; 1995 Jun; 4(2):101-8. PubMed ID: 8720152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Hennig M; Hundt F; Busta S; Mikus S; Sanden PH; Sörgel A; Ruppert T
    Ger Med Sci; 2017; 15():Doc02. PubMed ID: 28163667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of Imaging Part I: Perspectives for the Academic Radiologist.
    Duong PA; Bresnahan B; Pastel DA; Sadigh G; Ballard D; Sullivan JC; Buch K; Duszak R
    Acad Radiol; 2016 Jan; 23(1):18-22. PubMed ID: 26683508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research Statement.
    Kurbegov D; Hurley P; Waterhouse DM; Robert NJ; Nowakowski GS; Thompson MA; Bruinooge SS; Schilsky RL; Byatt L; Dempsey K; Dawson C; Hofacker J; Liu J; MacDougall AK; Kim ES
    JCO Oncol Pract; 2021 Jan; 17(1):41-51. PubMed ID: 33405975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.